Skip to Main Content
SickKids

Hereditary Spastic Paraplegia: Comprehensive Panel (AR/AD/XL)

Alternate test name

Hereditary Spastic Paraplegia: Comprehensive Panel (Autosomal Recessive, Autosomal Dominant, X Linked)

Gene name / Alternate gene name

ABCD1, ADAR, ALDH18A1, ALS2, AP4B1, AP4E1, AP4M1, AP4S1, AP5Z1, ATL1, ATP13A2, B4GALNT1, BSCL2, C19orf12, CAPN1, CPT1C, CYP2U1, CYP7B1, DDHD1, DDHD2, ERLIN1, ERLIN2, FA2H, FAR1, FARS2, GBA2, HACE1, HPDL, HSPD1, IBA57, IFIH1, KIDINS220, KIF1A, KIF1C, KIF5A, L1CAM, MAG, MTRFR, NIPA1, NT5C2, PCYT2, PLP1, PNPLA6, POLG, POLR3A, POLR3B, REEP1, REEP2, RNF170, RTN2, SACS, SELENOI, SETX, SLC16A2, SPART, SPAST, SPG11, SPG21, SPG7, TECPR2, TFG, TUBB4A, UBAP1, UCHL1, VPS13D, WASHC5, ZFYVE26

Lab area
Genome Diagnostics - Molecular Genetics
Method and equipment

Sequencing (all genes) by Next Generation Sequencing. Deletion & duplication analysis is also available for the genes on this panel by exon targeted microarray.

Expected turn-around time
Prenatal samples/Pregnancy/STAT: 2 weeks Routine: 6 weeks
Specimen type

Blood; please contact the Genome Diagnostics Laboratory if you want to send gDNA. If sending a prenatal sample, please contact the laboratory prior to sending sample to discuss sample requirements.

 

For details about specimen requirements, please refer to: Specimen Types & Requirements (PDF).

Specimen requirements
 
Blood: 5-10 mL in EDTA, 0.5 mL in EDTA (neonate);
DNA-minimum 10 ug in 100 uL low TE (pH8.0)
Storage and transportation
 
Blood- Room Temperature.  Please contact the Genome Diagnostics Laboratory if you want to send gDNA.

If sample shipment  >48 hours, ship on ice.
Special requirements
 
Special Instructions for Genome Diagnostics Samples

Please ship us the blood sample within 48 hours of collection. 
Shipping information
The Hospital for Sick Children
Division of Genome Diagnostics
555 University Avenue, Black Wing, Room 3416
Toronto, ON
Canada
M5G 1X8
Phone: 416-813-7200 ext. 2
Hours: Monday to Friday, 8 a.m. to 4:30 p.m.
Background and clinical significance

Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by lower limb spasticity and weakness with hyperreflexia and extensor plantar responses. HSP is estimated to affect 1 in 20,000 individuals in the European population. Clinically, HSPs can be divided into two main groups: uncomplicated (or pure) and complicated (complex) forms. Pure HSPs are characterized by spasticity in the lower limbs; whereas complex HSP forms are characterized by the presence of additional neurological or nonneurological features. The age of symptom onset, rate of symptom progression, and extent of disability are variable both within and between HSP families.

 

See related information sheets:

 

Hereditary Spastic Paraplegia 

Guide to Interpreting Sequence Variants

Guide to Next Generation Sequencing

Exons not part of NGS testing

Disease condition

Hereditary Spastic Paraplegia: Comprehensive Panel (Autosomal Recessive, Autosomal Dominant, X Linked)

Back to Top